Synopsis
Synopsis
0
KDMF
0
VMF
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Molecular Weight | 255.23 g/mol |
---|---|
Molecular Formula | C9H13N5O4 |
XLogP3 | -1.7 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 5 |
Exact Mass | 255.09675391 g/mol |
Monoisotopic Mass | 255.09675391 g/mol |
Topological Polar Surface Area | 135 A^2 |
Heavy Atom Count | 18 |
Formal Charge | 0 |
Complexity | 346 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 6 | |
---|---|
Drug Name | Cytovene |
PubMed Health | Ganciclovir (Injection) |
Drug Classes | Antiviral |
Drug Label | Ganciclovir is a synthetic guanine derivative active against cytomegalovirus (CMV). CYTOVENE-IV is the brand name for ganciclovir sodium for injection.CYTOVENE-IV is available as sterile lyophilized powder in strength of 500 mg per vial for intraveno... |
Active Ingredient | Ganciclovir sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 500mg base/vial |
Market Status | Prescription |
Company | Roche Palo |
2 of 6 | |
---|---|
Drug Name | Ganciclovir |
PubMed Health | Ganciclovir |
Drug Classes | Antiviral |
Drug Label | Ganciclovir is a synthetic guanine derivative active against cytomegalovirus (CMV).Ganciclovir is available as 250 mg and 500 mg capsules. Each capsule contains 250 mg or 500 mg ganciclovir, USP respectively, and inactive ingredients croscarmellose s... |
Active Ingredient | Ganciclovir sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 500mg base/vial |
Market Status | Prescription |
Company | Fresenius Kabi Usa; Luitpold |
3 of 6 | |
---|---|
Drug Name | Zirgan |
PubMed Health | Ganciclovir |
Drug Classes | Antiviral |
Drug Label | ZIRGAN (ganciclovir ophthalmic gel) 0.15% contains a sterile, topical antiviral for ophthalmic use. The chemical name is 9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]guanine (CAS number 82410-32-0). Ganciclovir is represented by the following structu... |
Active Ingredient | Ganciclovir |
Dosage Form | Gel |
Route | Ophthalmic |
Strength | 0.15% |
Market Status | Prescription |
Company | Bausch And Lomb |
4 of 6 | |
---|---|
Drug Name | Cytovene |
PubMed Health | Ganciclovir (Injection) |
Drug Classes | Antiviral |
Drug Label | Ganciclovir is a synthetic guanine derivative active against cytomegalovirus (CMV). CYTOVENE-IV is the brand name for ganciclovir sodium for injection.CYTOVENE-IV is available as sterile lyophilized powder in strength of 500 mg per vial for intraveno... |
Active Ingredient | Ganciclovir sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 500mg base/vial |
Market Status | Prescription |
Company | Roche Palo |
5 of 6 | |
---|---|
Drug Name | Ganciclovir |
PubMed Health | Ganciclovir |
Drug Classes | Antiviral |
Drug Label | Ganciclovir is a synthetic guanine derivative active against cytomegalovirus (CMV).Ganciclovir is available as 250 mg and 500 mg capsules. Each capsule contains 250 mg or 500 mg ganciclovir, USP respectively, and inactive ingredients croscarmellose s... |
Active Ingredient | Ganciclovir sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 500mg base/vial |
Market Status | Prescription |
Company | Fresenius Kabi Usa; Luitpold |
6 of 6 | |
---|---|
Drug Name | Zirgan |
PubMed Health | Ganciclovir |
Drug Classes | Antiviral |
Drug Label | ZIRGAN (ganciclovir ophthalmic gel) 0.15% contains a sterile, topical antiviral for ophthalmic use. The chemical name is 9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]guanine (CAS number 82410-32-0). Ganciclovir is represented by the following structu... |
Active Ingredient | Ganciclovir |
Dosage Form | Gel |
Route | Ophthalmic |
Strength | 0.15% |
Market Status | Prescription |
Company | Bausch And Lomb |
Hubei Gedian Humanwell focuses on R&D, production, & sales of fertility regulation drugs & steroidal APIs.
Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-01-30
Pay. Date : 2013-01-08
DMF Number : 15567
Submission : 2001-07-31
Status : Active
Type : II
Certificate Number : R1-CEP 2010-257 - Rev 03
Issue Date : 2021-09-30
Type : Chemical
Substance Number : 1752
Status : Valid
Registration Number : 222MF10281
Registrant's Address : NUERNBERGER STRASSE 12, 90537 FEUCHT, GERMANY
Initial Date of Registration : 2010-12-24
Latest Date of Registration : --
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-06-02
Pay. Date : 2015-08-07
DMF Number : 28973
Submission : 2015-04-02
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-03-07
Pay. Date : 2017-02-15
DMF Number : 31402
Submission : 2017-02-18
Status : Active
Type : II
NDC Package Code : 59651-108
Start Marketing Date : 2024-01-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23721
Submission : 2010-04-16
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16043
Submission : 2002-07-08
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27133
Submission : 2013-05-02
Status : Inactive
Type : II
Certificate Number : R1-CEP 2013-123 - Rev 01
Issue Date : 2019-06-20
Type : Chemical
Substance Number : 1752
Status : Valid
Date of Issue : 2024-04-23
Valid Till : 2027-04-22
Written Confirmation Number : WC-0170
Address of the Firm :
Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.
GDUFA
DMF Review : Complete
Rev. Date : 2013-01-30
Pay. Date : 2013-01-08
DMF Number : 15567
Submission : 2001-07-31
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2017-03-07
Pay. Date : 2017-02-15
DMF Number : 31402
Submission : 2017-02-18
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2016-06-02
Pay. Date : 2015-08-07
DMF Number : 28973
Submission : 2015-04-02
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27133
Submission : 2013-05-02
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16043
Submission : 2002-07-08
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23721
Submission : 2010-04-16
Status : Active
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?